The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Fostair 100 microgram/6 microgram per actuation pressurised inhalation solution



Chiesi Farmaceutici S.p.A.PA0584/008/001

Main Information

Trade NameFostair 100 microgram/6 microgram per actuation pressurised inhalation solution
Active SubstancesBeclometasone dipropionate
Formoterol fumarate dihydrate
Dosage FormPressurised inhalation, solution
Licence HolderChiesi Farmaceutici S.p.A.
Licence NumberPA0584/008/001

Group Information

ATC CodeR03AK08 formoterol and beclometasone

Status

License statusAuthorised
Licence Issued01/09/2017
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back